Meta‐Analysis of the Efficacy of Antibiotic Therapy in Eradicating Helicobacter pylori

The American Journal of Gastroenterology

Volumn 87, Issue 12, 1992, Pages 1716-1727

  Chiba, Naoki ^a   Rao, Babu V ^a   Rademaker, Johan W ^a   Hunt, Richard H ^a  

^a MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BISMUTH CITRATE; BISMUTH DERIVATIVE; METRONIDAZOLE; TETRACYCLINE; TINIDAZOLE;

ANTIBIOTIC THERAPY; ANTIMICROBIAL ACTIVITY; BACTERIAL INFECTION; COMBINATION CHEMOTHERAPY; DIARRHEA; DRUG EFFICACY; DRUG RESEARCH; DRUG TOLERANCE; GASTROINTESTINAL INFECTION; GASTROINTESTINAL SYMPTOM; HEADACHE; HELICOBACTER PYLORI; HUMAN; PEER REVIEW; PRIORITY JOURNAL; QUANTITATIVE ASSAY; REVIEW;

AMOXICILLIN; ANTI-INFECTIVE AGENTS; ANTIBIOTICS; ANTIBIOTICS, COMBINED; BISMUTH; CEFIXIME; CEFOTAXIME; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMAN; RESEARCH DESIGN; SENSITIVITY AND SPECIFICITY;

EID: 0026486714     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1992.tb07295.x     Document Type: Article

References (67)

1. Unidentified curved bacilli on gastric epithelium in active chronic gastritis
2. Unidentified curved bacilli on gastric epithelium in active chronic gastritis
3. Is antibacterial therapy against Campylobacter pylori useful in the treatment of indigastion and chronic peptic ulceration
4. Histological gastritis in duodenal ulcer: Relationship to Campylobacter pylori and effect of ulcer therapy
5. Bismuth subsalicylate in the treatment of gastritis due to Campylobacter pylori.
6. Campylobacter pylori: A role in non‐ulcer dyspepsia
7. Campylobacter pyloridis‐associated chronic active antral gastritis
8. The effect of bismuth subsalicylate on the histological gastritis seen with Campylobacter pvlori: A placebo‐controlled, randomized study
9. Campylobacter pylori‐associated gastritis: A double‐blind placebo‐controlled trial with amoxycillin
10. Campylobacter‐associated gastritis in patients with non‐ulcer dyspepsia: A double‐blind placebo‐controlled trial with colloidal bismuth sub‐citrate
11. Attempt to fulfill Koch's postulates for pyloric Campylobacter.
12. Ingestion of Campylobacter pyloridis causes gastritis and raised fasting gastric pH
13. Campylobacter (Helicobacter) pylori: Is peptic disease a bacterial infection
14. Campylobacter pylori and recurrence of duodenal ulcers: A 12‐month follow‐up study
15. Prospective double‐blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori.
16. Recurrence of duodenal ulcer and Campylobacter pylori infection after eradication
17. Cure of duodenal ulcer associated with eradication of Helicobacter pylori.
18. Helicobacter pylori: Controversies and an approach to management
19. Clinical significance of Campylobacter pylori.
20. Non‐ulcer dyspepsia and short term De‐nol therapy: A placebo‐controlled trial with particular reference to the role of Campylobacter pylori.
21. Efficacy of different dosage regimens of bismuth in eradicating Campylobacter pylori
22. Therapeutic attempts at eradication of Campylobacter pylori.
23. Campylobacter pylori: Its link to gastritis and peptic ulcer disease
24. The role of antibiotics in Campylobacter pylori‐associated peptic ulcer disease
25. Campylobacter pylori therapy review
26. Campylobacter pylori‐associated gastritis: Attempts to eradicate the bacteria by various antibiotics and anti‐ulcer regimens
27. Guidelines for reading literature reviews
28. Effect of acid inhibition on Campylobacter pylori.
29. SK. Natural history of Campylobacter pylori in duodenal ulceration treated with an H2‐antagonist
30. Reduction of gastric ulcer recurrence after suppression of Helicobacter pylori by Cefixime
31. Adjuvant antibiotic therapy in duodenal ulcers treated with colloidal bismuth subcitrate
32. Eradicating Helicobacter pylori and symptoms of non‐ulcer dyspepsia
33. Cure of duodenal ulcer after eradication of Helicobacter pylori
34. Does omeprazole improve antimicrobial therapy directed towards gastric Campylobacter pylori in patients with antral gastritis? A pilot study
35. Campylobacter pylori: Swedish experiences
36. Monotherapy or polychemotherapy in the treatment of Campylobacter pylori–relaled gastro‐duodenal disease
37. Campylobacter pylori in patients with dyspeptic symptoms and endoscopic evidence of erosion(s)
38. Five‐day bismuth–free triple therapy for the eradication of Helicobacter pylori and reduction of duodenal ulcer relapse
39. Colloidal bismuth + amoxicillin acute treatment and 4‐week follow‐up of Helicobacter pylori‐positive non‐ulcer dyspepsia
40. Evaluation of two short–term amoxycillin/tinidazole regimens for eradication of Helicobacter pylori.
41. Combined therapy with ofloxacin and amoxycillin in the eradication of Helicobacter pylori.
42. Eradication of Helicobacter pylori with colloidal bismuth subcitrate/antibiotic combinations
43. Long‐term follow‐up of C. pylori‐associated gastritis after treatment with colloidal bismuth subnitrate and/or amoxicillin
44. Treatment of Helicobacter pylori
45. Eradication of Campylobacter pylori infection with bismuth subsalicylate and antibiotic combinations
46. Long‐term follow‐up and antibody response to treatment of patients with Helicobacter pylori
47. Treatment of Helicobacter pylori
48. Oral triple therapy (OTT) may effectively eradicate Campylobacter pylori (Cp) in man: A pilot study
49. Helicobacter pylori therapy: Effect on peptic ulcer disease
50. Helicobacter pylori treated with combinations of tripotassium dicitrato and metronidazole: Efficacy of different treatment regimens and some observations on the emergence of metronidazole resistance
51. Helicobacter pylori infection treated with a tripotassium dicitrato bismuthate and metronidazole combination
52. Drug therapy for Helicobacter pylori infection: Problems and pitfalls
53. Short report: Short‐term triple therapy for H. pylori‐associated duodenal ulcer disease
54. Factors influencing the eradication of Helicobacter pylori with triple therapy
55. One‐week eradication regimen for Helicobacter pylori.
56. Helicobacter pylori eradication with doxycycline‐metronidazole‐bismuth subcitrate triple therapy
57. Possibilities for Helicobacter pylori suppression/eradication
58. Helicobacter pylori: Causal agent in peptic ulcer
59. The who's and when's of therapy for Helicobacter pylori.
60. Amoxicillin‐omeprazole treatment for eradication of Helicobacter pylori
61. Helicobacter pylori: Treatment with combinations of pivampicillin and tripotassium dicitrato bismuthate